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Objectives. This study was undertaken to assess the influence of 
the fluid volume state on cardiac adaptation to hypertension. 
Background. Left ventricular hypertrophy is an important 
predictor of hypertensive complications. We analyzed volume 
status and its impact on cardiac structural changes in early 
hypertension. 
Methods. In 33 normotensive subjects, 40 patients with border- 
line hypertension and 63 patients with established essential 
hypertension, mean arterial pressure was measured invasively; 
total blood volume was measured by iodine-125-1abeled plasma 
albumin and hematocrit; central blood volume by indocyanine 
green dye dilution curve; and diastolic diameter and left ventric- 
ular mass by two-dimensional-guided M-mode echocardiography. 
Results. Central blood volume was -20% higher in patients 
with stage I borderline hypertension than in normotensive sub- 
jects ([mean ± SD] 3,001 ± 663 vs. 2,493 -+ 542 ml, p < 0.05), 
whereas total blood volume was similar in all three groups. This 
shift in intravascular volume toward the cardiopulmonary circu- 
lation was accompanied by a significant increase in diastolic 
diameter (5.29 + 0.80 vs. 4.86 -+ 0.77 cm, p < 0.05) and in left 
ventricular mass (239.4 ± 90.6 vs. 183.5 -+ 68.8 g, p < 0.05) in 
patients with borderline hypertension compared with subjects 
with normotension. In patients with established essential hyper. 
tension, volume status of stroke volume and diastolic dimension 
returned to normal values, whereas left ventricular mass in- 
creased further. 
Conclusions. We conclude that the early phase of hypertension 
is characterized by centripetal distribution of intravascnlar vol- 
ume, leading to an increased preload to the left ventricle. This 
change in volume status appears to be related to cardiac struc- 
turai adaptation to an increase in arterial pressure. 
(J Am Coil Cardiol 1995;26:1692-8) 
Left ventricular hypertrophy is the hallmark of early cardiac 
structural adaptation i essential hypertension. Although myo- 
cardial hypertrophy was previously regarded as a compensa- 
tory, and thus physiologically necessary, process for offsetting 
increased wall stress of the left ventricle (1-4), it is well 
accepted that left ventricular hypertrophy is also a powerful 
independent risk factor for congestive heart failure, coronary 
artery disease and sudden cardiac death (5-8). Recent re- 
search indicates that left ventricular mass is a stronger predic- 
tor of hypertensive complications than blood pressure or other 
conventional risk factors (9) and that reduction of left ventric- 
ular hypertrophy by antihypertensive tr atment improves prog- 
nosis (10). 
The common view that the increase in left ventricular mass 
and the development of left ventricular hypertrophy are caused 
by an increase in afterload subsequent to functional and 
structural changes in the arterial vascular bed (11-14) is now 
challenged by evidence indicating that left ventricular hyper- 
trophy closely parallels peripheral vascular changes and may 
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already be detectable in early phases of hypertension (15-17), 
even before afterload becomes increased. Experimental data 
by Friberg et al. (18) showed that in rats, eccentric ardiac 
hypertrophy may develop rapidly in response to an increase in 
preioad, suggesting that the volume load of the heart may be 
an important factor in regulating the level of left ventricular 
mass. Other investigators (19-21) also provided evidence that 
hemodynamic volume load may be a stimulus to hypertensive 
left ventricular hypertrophy, in human as well as animal 
studies. This view is supported by a previous tudy from our 
laboratory (22) showing that total blood volume was a strong 
and pressure-independent predictor for chamber volume and 
left ventricular mass. Other factors proposed as influencing the 
pathogenesis of left ventricular hypertrophy, either through 
hemodynamic mechanisms or by directly promoting cardiac 
myocyte growth, are sodium intake (23,24), whole-blood vis- 
cosity (25,26) and neurohumoral substances. 
The provocative findings of de Simone et al. (27), that 
echocardiographic left ventricular mass in normotensive adults 
predicts future development of arterial hypertension, suggest 
that cardiac involvement may even precede clinically detect- 
able hypertension. This observation was confirmed by Iso et al. 
(28) and Post et al. (29). Thus, the time of onset and the 
interaction of various underlying pathogenetic mechanisms of
hypertensive heart disease are still unknown. To elucidate 
some of these questions, we evaluated cardiovascular and 
humoral findings in patients with borderline hypertension and 
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compared them with normotensive control subjects and pa- 
tients with established essential hypertension. 
Methods  
Study group. Included in the study were 136 subjects 
(mean [+SD] age 39.5 _+ ll.8 years; 90 men, 46 women; 104 
white, 32 black): 33 normotensive olunteers, 40 patients with 
borderline hypertension and 63 patients with established hy- 
pertension. Secondary causes of arterial hypertension were 
excluded by clinical evaluation. No patient had clinical signs of 
advanced hypertensive target organ damage, congestive heart 
failure, coronary artery disease or valvular and congenital 
cardiac lesions. All patients either had never been treated with 
antihypertensive m dication or had discontinued it at least 4 
weeks before being examined. Informed written consent was 
obtained before the study, and the protocol was approved by 
the Institutional Clinical Investigation Committee. 
Patients were considered to have borderline hypertension if 
some diastolic blood pressure values were >90 and some 
<90 mm Hg but were <95 mm Hg during at least four readings 
of ambulatory blood pressure measurements in the outpatient 
clinic (office blood pressure). Patients were considered to have 
established hypertension if their office diastolic blood pressure 
in the outpatient clinic was consistently >95 mm Hg. Office 
diastolic blood pressure values of the normotensive subjects 
were consistently <90 mm Hg. 
Echocardiography. Two-dimensional M-mode echocardio- 
graphic studies were conducted by standard methods, as 
previously outlined (30), by using an ultrasonoscope (Toshiba) 
interfaced with a strip chart recorder. All echocardiograms 
were recorded in the third or fourth interspace lateral to the 
left sternal border with the patient in the supine position. All 
echocardiograms were independently read by two physicians 
blinded to the characteristics, including the office blood pres- 
sure values, according to the standards of the American 
Society of Echocardiography (31). The coefficient variation of 
intra- and interobserver reproducibility was <5% for left 
ventricular dimensions and <10% for left ventricular wall 
thickness. Left ventricular structure was evaluated by septal 
and posterior wall thicknesses and systolic and diastolic diam- 
eters measured at the onset of the ORS complex. Left ventric- 
ular mass was calculated according to the standard formula of 
Troy et al. (32), which takes both septal and posterior wall 
thicknesses into account. However, left ventricular mass deter- 
mined by this method needs to be adjusted by the regression 
PENN cube left ventricular mass of 0.80 (ASE cube left 
ventricular mass) plus 0.6 g to avoid systematic overestimation 
(33-36). 
Hemodynamic, volume and humoral measurements. He- 
modynamic evaluation was performed after overnight fasting 
as previously described (37). There was a maximum of 7 to l0 
days between the office blood pressure screening and the 
hemodynamic study. Within this period the subjects were 
asked to maintain astable life-style with regard to drinking and 
Table 1. Demographic Characteristics in Normotensive Control 
Subjects and Patients With Borderline Hypertension r Established 
Essential Hypertension 
NT BH EH 
(n = 33) (n = 40) (n = 63) 
Age (yr) 33 -+ 10 35 ± 4 45 ± ll*l 
Race (white/black) 28/5 34/6 42/21 
Gender (male/female) 22/11 32/8 36/27 
Weight (kg) 80 ± 18 85 ± 19 81 ± 18 
Height (cm) 171 ± 10 176 ± 10':~ 171 ± 10 
Body mass index (kg/m 2) 27.2 ± 5.8 27.3 ± 5.2 27.8 ± 5.8 
Body surface area (m 2) 1.9 ± 0.2 2.0 _+ 0.2 1.9 ± 0.2 
*p < 0.05 versus normotensive control subjects (NT). tp < 0.05 versus 
patients with borderline hypertension (BH). *p < 0.05 versus patients with 
established ssential hypertension (EH). Data presented are mean value + SD 
or number of subjects. 
eating habits. Briefly, catheters were inserted into a brachial 
artery and an antecubital vein and advanced to the ascending 
aorta and superior vena cava, respectively. Thus, arterial 
pressure was measured continuously, simultaneously with the 
recording of the electrocardiogram (lead Ill). Cardiac output 
was measured in triplicate with the indocyanine green dye 
technique. Stroke volume and total peripheral resistance were 
calculated by standard formulas. Plasma volume was measured 
during the hemodynamic study with iodine-125-1abeled plasma 
serum albumin (38). Total blood volume was estimated from 
the plasma volume and hematocrit: Total blood volume = 
Plasma volume/(100 - Hematocrit), with the hematocrit hav- 
ing been adjusted by the correction factor 0.91 for total body 
hematocrit. Central blood volume was assessed from the 
indocyanine green dye dilution curve by calculating the prod- 
uct of mean transit time and blood flow per second as 
previously outlined in detail (39,40). When the patients had 
been recumbent for at least 1 h after the insertion of the 
catheters, blood was withdrawn into ice-cooled tubes and 
stored at -21°C for later determinations of circulating plasma 
norepinephrine and epinephrine l vels (radioenzymatic assay) 
and plasma renin activity (radioimmunoassay). 
Statistics. One-way analysis of variance and the Bonfer- 
roni correction were used to evaluate any significant difference 
between the groups. Statistical significance was considered 
to be p < 0.05 (two-tailed). All data are expressed as mean 
value _+ 1 SD, unless otherwise specified. 
Results 
Demographic haracteristics. There were no significant 
differences in gender, race, weight, body mass index or body 
surface area between the normotensive control and borderline 
and established essential hypertension groups (Table 1). Pa- 
tients with established hypertension were older than the nor- 
motensive subjects and the patients with borderline hyperten- 
sion (p < 0.05), and the borderline hypertensive group was 
taller than the other two groups (p < 0.05) (Table 1). 
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Table 2. Hemodynamic, Volume and Humoral Findings in Normotensive Subjects and Patients With 
Borderline Hypertension r Established Essential Hypertension 
NT BH EH p Value 
Systolic arterial pressure (mm Hg) 121.7 - 10.1 132.4 _+ 13.3" 157.5 -+ 13.2"f <0.0001 
Diastolic arterial pressure (ram Hg) 72.2 + 6.8 78.5 _+ 7.4* 88.4 _+ 8.1*f <0.0001 
Mean arterial pressure (mm Hg) 882 -+ 7.4 %.5 + 8.7* 111.4 _+ 8.2** <0.0001 
Heart rate (beats/rain) 68.0 + 9.0 66.1 + 10.3 68.9 _+ 9.8 NS 
Cardiac output (liters/rain) 5.8 +_ 1.5 6.6 _+ 1.6'$ 5.8 -+ 1.3 <0.02 
Cardiac index (liters/rain per mZ) 3.1 + 0.7 3.3 _+ 0.8 3.0 _+ 0.6 NS 
Stroke volume (ml/min) 87.0 + 22.2 100.7 + 22.1'$ 85.2 +_ 19.9 0.001 
Total blood volume (ml) 4,795 _+ 888 5,(}51 *_ 916 4,642 + 1023 NS 
Plasma volume (ml) 2,911 + 566 3,071 _+ 539 2,867 +- 577 NS 
Central blood volume (ml) 2,493 ~ 542 3,{X)I _+ 663*$ 2,626 _+ 516 0.001 
Total blood volume/height (ml/cm) 27.9 * 4.1 28.6 _+ 4. I 27.1 _+ 5.1 NS 
Plasma volume/height (ml/cm) 17.0 + 2.8 17.4 _+. 2.5 16.8 _+ 2.9 NS 
Central blood volume/height (ml/cm) 14.6 +_ 2.8 16.9 _+ 3.4*$ 15.2 z 2.6 0.003 
Stroke volume/height (ml/cm) 0.51 ± 0.11 0.57 _+ 0.11'$ 0.50 + 0.11 0.005 
Total peripheral resistance (U) 16.1 + 4.4 15.4 _+ 4.0 20.1 _+ 4.6*? <0.0001 
Norepinephrine 267 + 157 341 +_ 172 299 + 128 NS 
Epinephrine 1il9 + 65 143 _+ 1125 71 +_ 73 <0.05 
Renin 0.ql + 1.1 1.0 _+ 0.8 1/.95 _+ 1.2 NS 
*p < 0.05 versus normotensive control subjects (NT). *p < 0.05 versus patients with borderline hypertension (BH). 
Sp < 0.05 versus patients with established essential hypertension (EH). Data presented are mean value +_ SD. 
Hemodynamic, volume and humoral findings. Arterial 
pressure measured invasively was higher in the patients with 
borderline hypertension a d established hypertension than in 
the normotensive subjects (Table 2, Fig. 1). Stroke volume was 
significantly increased in patients with borderline hypertension 
compared with the normotensive subjects and the patients with 
established hypertension (100.7 _+ 22.1 vs. 87.0 + 22.2 and 
85.2 _+ 19.9 ml, respectively, p < 0.05) (Table 2, Fig. 1). The 
increase in stroke volume in this group was accompanied by a 
significant increase in cardiac output (6.6 _+ 1.6 vs. 5.8 _+ 1.5 
liters/rain in the normotensive group and 5.8 _+ 1.3 liters/rain in 
Figure 1. Differences in central blood volume (CBV), total blood 
volume (TBV), stroke volume (SV) and cardiac output (CO) among 
the three study groups. BH = patients with borderline hypertension; 
EH = patients with essential hypertension; NT = normotensive 
control subjects. 
CBV (ml) . + TBV (ml) 
6000~ 
SV (ml) CO (I/rain) 
NT BH EH NT BH EH 
* p<O.05 vs NT + p<0.05 vs EH 
the group with established hypertension, p < 0.05) (Table 2, 
Fig. 1). Total peripheral resistance was significantly increased 
in the patients with established hypertension compared with 
the other two groups (p < 0.001) (Table 2). 
Patients with borderline hypertension showed a marked 
increase in central blood volume that was -20% higher than 
that in the normotensive control subjects (3,001 + 663 vs. 
2,493 + 542 ml, p < 0.05) (Table 2, Fig. 1), whereas plasma 
volume and total blood volume were similar in all three groups, 
indicating ashift of the circulating intravascular volume toward 
the cardiopulmonary circulation in early hypertension. When 
corrected for differences in body height, total blood volume 
and plasma volume were again not different among the groups. 
In contrast, central blood volume corrected for height still 
showed an increase in the patients with borderline hyperten- 
sion compared with the normotensive subjects and those with 
established hypertension (116.9 _+ 3.4 vs. 14.6 +_ 2.8 and 15.2 _+ 
2.6 ml/cm, respectively, p < 0.05) (Table 2). Although some- 
what higher in the patients with borderline hypertension, 
norepinephrine and renin levels were not significantly different 
in the other groups. However, epinephrine l vels were higher 
in patients with borderline hypertension than in those with 
established hypertension (p < 0.05) but was not significantly 
different in the normotensive control group (Table 2). 
Eehocardiographic findings. As expected, echocardio- 
graphic determination f septal and posterior wall thickness 
revealed higher values in patients with established essential 
hypertension than in the other groups (Table 3, Fig. 2). 
Compared with the normotensive subjects, those with border- 
line hypertension exhibited an increase in septal thickness 
(9.9 +_ 1.8 vs. 8.8 + 1.9 ram, p < 0.05) (Table 3, Fig. 2) but not 
in posterior wall thickness. Furthermore, there was also a 
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Table 3. Echocardiographic Findings in Normotensive Control Subjects and Patients With Borderline 
Hypertension r Established Essential Hypertension 
P 
NT BH EH Value 
Septal thickness (ram) 
Posterior wall thickness (mm) 
Diastolic diameter (cm) 
Systolic diameter (cm) 
Left ventricular mass (g) 
Left ventricular mass index (g/m 2) 
Left ventricular mass/height (g/m) 
Relative wall thickness (2 PWT/DD) 
8.8 -+ 1.9 9.9 _+ 1.8" 11.1 • 2.2"t <0.001 
8.4 -+ 1.4 9.0 _+ 1.3 10.0 --- 1.5'? <0.001 
4.86 -+ 0.77 5.29 _+ 0.80*¢ 4.79 ± 0.60 0.002 
3.13 +- 0.63 3.50 _+ 0.62':~ 3.10 --- 0.54 0.003 
183.5 -+ 68.8 239.4 +_ 90.6* 232.4 -- 67.4* 0.003 
96.4 _+ 36.5 122.2 _+ 53.7* 121.9 ± 37.0* 0.01 
108 -+ 41 138 _+ 57* 137 ± 39* 0.007 
0.36 - 0.02 0.35 -+ 0.01 0.42 ± 0.008'~" <0.001 
*p < 0.05 versus normotensive control subjects (NT). ~p < 0.05 versus patients with borderline hypertension (BH). 
:~p < 0.05 versus patients with established essential hypertension (EH). Data presented are mean value _+ SD. DD = 
diastolic diameter; PWT - posterior wall thickness. 
significant increase in left ventricular end-diastolic diameter in 
patients with borderline hypertension compared with normo- 
tensive subjects (5.29 _+ 0.80 vs. 4.86 ___ 0.77 cm, p < 0.05) 
(Table 3, Fig. 2). Most important, in comparison with the 
normotensive subjects, left ventricular mass was significantly 
increased not only in the patients with established hyperten- 
sion but also in those with borderline hypertension (239.4 _+ 
90.6 vs. 183.5 -+ 68.8 g, p < 0.05) (Table 3, Fig. 2). 
Influence of gender on findings in borderline hypertension. 
Because women have a lower blood volume and cardiac output 
than men, we addressed the question of whether this variation 
in gender distribution may have had any influence on the 
results (Table 1). The male borderline hypertensive group 
exhibited increases in central blood volume (3,212 _ 660 vs. 
2,693 _ 496 ml, p < 0.05), diastolic diameter (5.22 _+ 0.66 
vs. 4.86 __+ 0.67 cm) and left ventricular mass (236.2 -+ 68.1 vs. 
190.4 -+ 69.3 g) compared with the male normotensive group. 
In the female borderline hypertensive group compared with 
the female normotensive group, a trend was also found for an 
Figure 2. Differences in septal thickness (ST), posterior wall thickness 
(PWT), left ventricular end-diastolic dimension (LVEDD) and left 
ventricular mass (LVM) among the three groups. Other abbreviations 
as in Figure 1. 
ST (mm) . + PWT (ram) . + 
11; * 10 




NT BH EH NT BH EH 
• p<o.05 vs NT + p<0.05 E]H vs EH 
increase in central blood volume (2,446 ___ 297 vs. 2,133 _ 447 
ml) and diastolic diameter (5.38 _+ 1.23 vs. 4.87 _.+ 0.99 cm); 
however, statistical significance was not reached because of the 
small sample size (n = 8). Nevertheless, the increase in left 
ventricular mass (261.9 - 145.8 vs. 169.6 - 68.9 g) was 
significant (p < 0.05), even with this small number of female 
patients. Thus, the findings in the female borderline hyperten- 
sive patients appeared to parallel those seen in the group of 
male borderline hypertensive patients. This subanalysis sug- 
gests that the variation in gender distribution had no major 
influence on the main results of the study. 
"Stage I" versus "stage II" borderline hypertension. To 
define more accurately the point at which the first hemody- 
namic and cardiac structural changes occur in the evolution of 
essential hypertension, weperformed a subanalysis of the data 
by subdassifying the patients with borderline hypertension into 
two groups according to their blood pressure pattern during 
invasive measurement at rest in the hemodynamic laboratory: 
stage I borderline hypertension (n = 28) = normal diastolic 
pressure (i.e., <90 mm Hg); and stage II borderline hypertension 
(n -- 12) = diastolic blood pressure >90 mm Hg. Compared 
with normotensive control subjects, stage I borderline hyper- 
tensive patients were characterized bysignificant increases in 
stroke volume (102.6 _ 19.9 vs. 87.0 -+ 22.2 ml/min, p < 0.05) 
and central blood volume (3,060 _ 679 vs. 2,493 +_ 542 ml, p < 
0.05), whereas total blood volume and plasma volume were 
unchanged (Table 4). These differences persisted when cor- 
rected for body height. The main echocardiographic f ndings 
seen in the group with borderline hypertension as a whole 
(Table 3, Fig. 2) could be detected in the stage I borderline 
hypertensive patients. Compared with normotensive subjects, 
left ventricular end-diastolic diameter and left ventricular 
mass were significantly increased in patients with stage I 
borderline hypertension (5.26 _ 0.84 vs. 4.86 + 0.77 cm, p < 
0.05; 237.8 _ 93.3 vs. 183.5 _+ 68.8 g, p < 0.05, respectively) 
(Table 4). Stage II borderline hypertension, characterized by
constantly elevated pressure values at rest, appeared to be 
somewhat intermediate b tween stage I borderline hyperten- 
sion and established hypertension, although no significant 
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Table 4. Hemodynamic, Volume and Echocardiographic Findings in Patients With Stage I and II Borderline Hypertension, Normotensive 
Control Subjects and Patients With Established Essential Hypertension 
BH 
NT Stage I Stage II EH p 
In = 33) (n = 28) (n - 12) (n = 43) Value 
Mean arterial pressure (mm Hg) 
Cardiac output (liters/min) 
Stroke volume (ml/min) 
Central blood volume (ml) 
Total blood volume (ml) 
Plasma volume (ml) 
Total blood volume/Seight (ml/cm) 
Plasma volume/height (ml/cm) 
Central blood volume/height (ml/cm) 
Septal thickness (ram) 
Posterior wall thickness (mm) 
Diastolic diameter (cm) 
Left ventricular mass (g) 
Left ventricular mass/height (gc'cm) 
88.7 +_ 7.4 92.3 _+ 6.7 106.2 ± 2.8"? 111.4 ± 8.2*$ <0.001 
5.8 = 1.5 6.6 _+ 1.6 6.6 ± 1.7 5.8 ± 1.3 NS 
87.0 _~ 22.2 102.6 + 19.9"§ 96.2 _+ 27.1 85.2 ± 19.9 <0.003 
2,493 + 542 3,(160 + 679*§ 2,880 _+ 640 2,626 ± 516 0.002 
4,795 z 888 5,1184 2-- 910 4,968 _+ 968 4,641 + 1023 NS 
2,911 = 566 3,1N9 _+ 530 3,005 ± 579 2,867 + 577 NS 
27.9 = 4.1 28.7 z 4.1 28.4 + 4.4 27.1 ± 5.1 NS 
17.0 + 2.8 17.5 z 2.5 17.1 ± 2.7 16.8 ± 2.9 NS 
14.6 = 2.8 17.2 ± 3.5*§ 16.4 ± 3.1 15.2 ± 2.6 0.006 
8.8 - 1.9 9.9 +_ 1.9' 9.8 ± 1.7 11.1 + 2.2*$ <0.0001 
8.4 + 1.4 9.11 --_ 1.3 9.0 ± 1.3 10.0 ± 1.5'$ <0.0001 
4.86 ~ 11.77 5.26 = 0.84*§ 5.35 ± 0.74 4.79 ± 0.60 <0.007 
183.5 _+ 68.8 237.8 z 93.3* 243.2 ± 87.8 232.4 ± 67.4* 0.009 
1.1 + 0.4 1.4 = 0.6* 1.4 ± 0.6 1.4 _+ 0.4* 0.02 
*p < 0.05 versus normotensive control subjects (NT). ?p < 0.05 versus patients with stage 1 borderline hypertension (BH). Sp < 0.05 versus patients with stage 
II borderline hypertension. §p < 0.05 versus patients with established essential hypertension (EH). Data presented are mean value ± SD. 
difference was observed between stage I and stage II border- 
line hypertension (Table 4). 
Discuss ion  
The present cross-sectional study focused on the hemody- 
namic, volume and cardiac structural differences between a
normotensive control group and patients with different degrees 
of arterial hypertension. 
Borderline hypertension, known to be associated with a 
higher risk of established hypertension and for excessive 
cardiovascular morbidity and mortality (4:1,42) was character- 
ized hemodynamically b increases in central blood volume, 
stroke volume and cardiac output, indicating a centripetal 
redistribution of total blood volume. Echocardiographically, 
diastolic diameter and left ventricular mass were increased, 
demonstrating aneccentric type of cardiac remodeling. 
Pathophysiologic mechanisms. Our data confirm previous 
findings from this laboratory (43) showing that patients with 
borderline hypertension exhibit a cardiopulmonary redistribu- 
tion of intravascular volume. Furthermore, the subclassifica- 
tion of the patients with borderline hypertension allowed us to 
define more exactly the point at which the first hemodynamic 
and cardiac structural changes occur in the evolution of 
essential hypertension. Thus, a shift in the circulating intravas- 
cular volume toward the cardiopulmonary circulation, as indi- 
cated by a marked increase in central blood volume, was 
already evident in patients with stage I borderline hyperten- 
sion. Central blood volume was still significantly increased in 
this early phase of hypertension, although plasma volume, total 
blood volume, weight, body mass index and body surface area 
were not significantly different among the groups. This centrip- 
etal redistribution of the intravascular volume implies the 
active participation of the capacitance vessels, suggesting vc- 
nous constriction in the patients with early borderline hyper- 
tension. The underlying pathophysiologic mechanism for this 
increase in peripheral venous tone may be an increase in 
sympathetic vasoconstrictor activity. Indeed, evidence from 
measurements of plasma catecholamines, from responses to 
adrenergic agonists and antagonists and, more recently, from 
direct measurements of sympathetic nerve activity to the 
muscle circulation (44-50) indicates that sympathetic a tivity is 
increased in borderline hypertension. Plasma catecholamine 
levels, although not the best measure of sympathetic a tivity 
(51), in the present study at least indicate a trend toward 
higher values in the group with borderline hypertension. 
Central blood volume, stroke volume and cardiac output 
levels in the patients with established hypertension were very 
similar to those observed in the normotensive control subjects. 
Because of the relatively small sample size in the stage II 
borderline hypertension group (i.e., the patients with presum- 
ably more advanced hypertensive disease), caution must be 
taken when making statements about any differences or lack of 
differences between this group and the other groups. Never- 
theless, the data obtained at least indicate that the initial shift 
in intravenous volume to the cardiopulmonary circulation that 
characterizes the very early phase of essential hypertension 
(i.e., stage I borderline hypertension) tends to return to normal 
as the disease progresses. Similarly, our data support the 
concept hat after an initial increase, cardiac output decreases 
toward normal values, and peripheral resistance increases as 
the disease evolves, indicating a shift from a high volume/ 
cardiac output hypertension to a high total peripheral resis- 
tance hypertension (52). 
Effect on cardiac structure. In a further extension of 
earlier data from this laboratory, we were able to document 
that the hemodynamic and volume changes in borderline 
hypertension go hand in hand with cardiac structural changes. 
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Left ventricular mass together with left ventricular end- 
diastolic diameter was significantly increased in this group, 
having been already evident in patients with stage I borderline 
hypertension. In the patients with established hypertension, 
left ventricular mass remained elevated, whereas left ventric- 
ular end-diastolic diameter decreased toward normal, giving 
rise to the classic form of concentric left ventricular hypertro- 
phy. A limitation of the study was the fact that the two- 
dimensional M-mode echocardiographic technique is not suf- 
ficiently accurate to distinguish load-dependent changes in 
dimension (Frank-Starling mechanism) from "true" shifts in 
the pressure-volume relation, which would require more de- 
tailed invasive hemodynamic measurements. Nevertheless, the 
M-mode echocardiographic technique is a commonly per- 
formed and accepted means of accurately measuring cardiac 
diameter and wall thickness. By using this technique, we could 
show that in borderline hypertensive patients these measures 
are increased, so the ratio between wall thickness and diastolic 
diameter remains normal. Data supporting an increase in 
plasma volume in hypertensive patients with eccentric left 
ventricular hypertrophy and a decrease in patients with con- 
centric left ventricular emodeling have been provided by 
Ganau et al. (53,54). 
Conclusions. Taken together, the present data add to the 
growing evidence that hypertensive disease encompasses more 
than increased blood pressure, even to the extent that cardio- 
vascular function and structure may be affected before blood 
pressure is markedly elevated or total peripheral resistance is 
increased. 
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